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STUDIES ofthe mechanism of action ofthe polycyclic hydrocarbons within the
animal bodyhave beenmainly concerned withgross effects. Specific action within
particular tissues has only been touched upon, whilst action within the individual
cells of tissues has been barely considered. An understanding of the mechanism
of carcinogenesis must involve a knowledge of the intracellular behaviour of the
carcinogenic agent. Benzpyrene is a very suitable agent for such studies as it can
be traced by way ofits fluorescence and absorption spectra. Additionally, certain
information is available as to the nature and properties of the primary metabolic
derivatives.
Founded upon these considerations we have attempted a detailed investigation
of the action of 3: 4 benzpyrene within cells, both from the aspect of metabolic
change of the hydrocarbon itself and from the viewpoint of effects upon cellular
constituents. Throughout the work wehave endeavoured to consider the problem
in relation to the cell structure as any interpretation ofbiological behaviour must
be couched in terms of cell morphology to be intelligible.
The present paper details the results obtained in studies of the sites at which
benzpyrene is oxidised within mouse liver. A preliminary account of this work
has appeared, (Calcutt and Payne, 1954).
Present knowledge of benzpyrene metabolism.
The starting point for the present series of investigations is the data collected
by Weigert and Mottram (1946a, 1946b). These authors reviewed the existing
knowledge and then gave a detailed account of experiments designed to trace the
primary steps in the metabolism of benzpyrene in whole tissues. They isolated
and characterised two compounds as primary metabolites which were labelled
as BpXj and BpX2. By physical methods and analogy with known derivatives
of other polycyclic hydrocarbons these were shown to be:
8 (OR1) - 9 (OH)- 8, 9 dihydro- 3, 4benzpyrene (BpX,) and
8 (OR1) - 9 (OR2) - 8,9 dihydro- 3, 4 benzpyrene (BpX2).
The radicals R1 and R2 are unknown.
These two compounds were formed in the tissues where benzpyrene was meta-
bolised and then converted to the final excretion products, 8. OH benzpyrene and
5: 8 benzpyrene quinone, during their passage through the animal body. A
further compound labelledBpF1 and believed to be 8 (0R1)-3, 4 benzpyrene, was
found to occur as an intermediate stage in the dehydration of BpXj to 8.OHINTRACELLULAR METABOLISM OF BENZPYRENE
benzpyrene. In the course of this work it was found that the benzpyrene deriva-
tives present in a tissue at any particular time were firmly bound to tissue consti-
tuents and could only be separated after treatment with acetone.
More recently, Miller (1951) has found that benzpyrene applied to mouse skin
becomes firmly bound to a protein fraction. Using fluorescence spectroscopy as
the detecting method Calcutt and Payne (1953) found benzpyrene to persist in the
nuclei and mitochondria of mouse liver for long periods after intraperitoneal
injection ofthe carcinogen. This parallels the finding by Wiest and Heidelburger
(1953) that 1: 2: 5: 6 dibenzanthracene is bound in the nuclei, mitochondria,
microsomes and supernatant ofsubmaxillary glands ofmice after local application
of the hydrocarbon.
The work summarised above forms the foundation of our present researches.
Materials used.
Young mice of either the Strong A or R III strains were used in all experi-
mnents. Early experience showed that there was no detectable strain differences
in metabolism so mice were used as available. The liver was chosen for first
experiments as being easilyhandled, ofadequate bulk, and as a site where metabo-
lism of benzpyrene is known to occur. The benzpyrene was from a stock held in
thislaboratoryand giving an absorption spectrum identicalwiththose inthelitera-
ture for the pure hydrocarbon.
The ultimate aim was the detection of metabolites by spectroscopic methods,
so all reagents used were selected as being of "Analytical Reagent" quality.
Organic solvents were either purchased as suitable for spectroscopic work or
further purified to remove interfering contaminants. Silica for chromato-
graphy was prepared by the method of Gordon, Martin and Synge (1943); the
fraction of 100/150 mesh being used. Alumina was a commercially available
product.
Preliminary experiments.
Sincebenzpyrene has been shown to be concentrated innuclei and mitochondria
attempts were made to determine whether metabolism occurs at these sites. At
intervals after the intraperitoneal injection of 0.1 mg. of benzpyrene into mice
the animals were killed, the livers removed and the nuclei and mitrochondria
extracted in 0.88 M sucrose solution. Extracts ofthese fractions were made with
various solvents including ethyl alcohol, ethyl ether, amyl alcohol, benzene and
cyclohexane. Examination of the extracts in the spectrophotometer showed the
presence of benzpyrene together with various unidentifiable substances derived
from the tissue fraction. As it was likely that the spectra of any metabolites
present were being obscured by other compounds, purification was attempted by
chromatography on either alumina or silica columns. No metabolites were found,
but it was discovered that a yellow pigmented substance could be extracted from
both nuclei and mitochondria. This could not be separated from benzpyrene on
alumina columns, but obviously had no connection with the problem since it
could also be extracted from nuclei and mitrochondria from untreated control
animals. Spectroscopically this substance showed a steady fall over the region
220-340 mj. and then two maxima at 367 and 387 mu. In the presence ofbenz-
pyrene it showed the superimposed maxima of the hydrocarbon at 265 m,u.,
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285 m/t. and 296 m/t. and ill-defined maxima spread over 365-367 m,. and 384-
387 m,t. The spectra obtained in this fashion closely resemble that found for a
believed benzpyrene metabolite from rats by Reggiani, Dansi and Morelli (1939).
As these authors prepared their material by extraction with benzene and chroina-
tography on alumina we are of the opinion that their finding was of a mixture
of benzpyrene and an unknown cell constituent and, like ours, cannot be a
benzpyrene derivative.
Another series of experiments was undertaken in collaboration with Dr. R.
Barer ofthe Department of Human Anatomy, Oxford. These were based on the
finding by Barer, Ross and Tkacyzk (1953) that suspension of living particulate
material in a medium of the same refractive index as the material itself will,
provided that leakage of the external medium into the particles does not occur,
produce a suspension which is virtuallytransparent. Mitochondria were extracted
from normal and benzpyrene-treated livers of rats and mice. On immersion in
suitable solutions of purified bovine plasma albumin and examination by phase
contrast microscopy it was found that phase reversal occurred at protein concen-
trations equivalent to 50-52 per cent solid matter. No distinction was detected
between the mitochondria from normal livers and those from the hydrocarbon
treated tissue. Thick suspensions of mitochondria were made in appropriate
protein solutions and examined in the spectrophotometer; protein solution being
used in the control cell. The spectra obtained were useless for our purposes as the
absorption by normal constituents of the mitochondria completely masked any
due to the hydrocarbon or its derivatives. These experiments did, however,
demonstrate that freshly prepared mitochondria are impervious to albumin
solutions. This suggests that the mitochondria membranes demonstrated by
Sj6strand (1953) should be regarded as semi-permeable.
Ultimately we adopted a method for the extraction and purification of ineta-
bolites founded upon that devised by Weigert and Mottram (1946a).
Separation ofcellfractions and isolation ofbenzpyrene metabolites.
Batches of 6-8 mice were injected intravenously via the tail vein with 0-5 c.c.
of colloidal benzpyrene in water, the concentration being such that each mouse
received approximately 0.05 mg. of the hydrocarbon. This route of administra-
tion was adopted as being the one best calculated to give a concentration of
hydrocarbon in the liver. At various preselected intervals after the injection the
mice were killed, the livers removed and homogenised in Tyrode solution. This
latter was selected as the homogenising medium as it was desired to maintain the
pHabove 7-0sinceconversionofBpX1andBpX2 to 8.OHbenzpyrenoloccurs under
acid conditions. The liver suspension was strained through four layers of gauze
to remove fibrous tissue and then spun down at 1,500 x g. for 15 minutes to sedi-
ment the nuclei. Mitochondria were collected after spinning for 20 minutes at
22,000 x g. in the Spinco Ultracentrifuge, and the microsomes were removed by a
final spinning at 25,000 X g. for 30 minutes. The nuclear and mitochondrial
fractions were each resuspended in Tyrode and spun down again to free them of
contaminant material.
Acetone was then poured into each of the four fractions: nuclei, mitochon-
dria, microsomes and supernatant. After a few minutes the acetone was removed
by boiling off under reduced pressure and the fractions were repeatedly extracted
with individual small portions of xylene. This was repeated until no further
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fluorescent material was extracted. The xylene samples from each fraction were
pooled together, dried over anhydrous sodium sulphate and passed through a
chromatograph column comprised of silica layered over alumina. It had been
found previously by Weigert and Mottram (1946a) that under these conditions
BpX1 and BpX2 are adsorbed at the surface ofthe silica, the phenolic derivatives
BpF1 and 8.OH benzpyrene are adsorbed on the alumina and unchanged benz-
pyrene appears in the eluate.
After suitable washing with pure xylene the columns were extruded and cut
into portions as determined by the positions of adsorbed fluorescent material.
The individual portions were eluted with ethyl alcohol and then examined in the
Unicam Spectrophotometer; ethyl alcohol being used in the control cell. Spectra
were taken over the range 340-430 m,. and compared with those published by
Weigert and Mottram (1946a). In most cases one or more further chromato-
graphic purifications were necessary before the spectra could be considered as
representative of the compounds under investigation. Even under these circum-
stances the spectra were poor as they were derived from very small amounts of
material and often still showed indications of contaminants. Confirmation of
the nature of any one sample as determined by absorption spectroscopy was
sought in its behaviour on the chromatograph columns and its fluorescence
spectrum. Determinations of metabolites as detailed below are then based on
a combination of absorption spectra, fluorescence spectra and chromatographic
behaviour.
Experimentalfindings.
The experiments in this series were only carried on over a period of up to
24 hours, since the bulk of benzpyrene deposited in the liver after intravenous
injection is excreted within this time period. The general results are detailed
in Table I.
TABLE I.-Benzpyrene and Derivatives in Mouse Liver Fractions after Intravenous
Injection of the Colloidal Hydrocarbon.
Number
of mice
used.
6
-S 7
7
5
7
Time
between
injection
and killing
(hours).
21
4
8
12
17
17
Extraction
medium.
Tyrode
(pH-7.6)
Tyrode
(pH-7.6)
Tyrode
(pH-7'6)
Tyrode
(pH-7-6)
Sucrose 0-88 Mi .
(pH-6-8)
Tyrode
(pH-7-6)
. 1 per cent citric.
acid
(pH-2-6)
Findings.
I I
Nuclei.
Bp; BpX2
Bp; BpX2
Bp; BpX2
Mitochondria. Microsomes. Supernatant.
Bp; BpX, Bp Bp (trace)
BpX2 BpX,; BpX,
Bp; BpX2 BpXL; BpX2
Bp; BpX2 Bp; BpX, Bp (Trace)
BpX,1; BpX2
Bp; BpX, Bp; BpX, BpX2
Bp; BpX2
Bp; BpX2
Bp; BpX2
Bp; BpX2
Bp; BpX2
BpX,2 Bp
BpX. BpX,BpX
BpXo Bp BpX,; BpX,
BpX2 BpXL; BpX2
BpF1; BpF2
. 17 Tyrode . Bp; BpX BpX2 BpX,
(pH-7'6)
. 24 . Tyrode . Bp; BpX,' Bp; BpX2 Bp; BpX2 (pH-7-6)
Abbreviations used: Bp. = 3: 4 benzpyrene.
BpX, = 8 (OR1) - 9(OH) 8,9-dihydro 3: 4 benzpyrenc.
BpX2 -= 8 (OR1)- 9(OR2) 8,9-dihydro 3: 4 benzpyrene.
BpF, = 8 (OR1) 3: 4 benzpyrene.
BpF2 = 8.OH 3: 4 benzpyrene.
Blank space means that the particular fraction was not examined.
BpXl
Bp (Trace)
BpX,; BpX2
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In carrying out these experiments we were aware that saline solutions are
perhaps not the best media for extraction of cell fractions. We have therefore
checked our general results by some extractions in other media. Citric acid
(1 per cent) was used according to the technique of Mirsky and Pollister (1946)
as in our experience this gives the best yield of nuclei uncontaminated by other
cell constituents. Sucrose (0.88 M) was also used as advocated by Hogeboom,
Schneider and Pallade (1948) in order to achieve well preserved mitochondria of
a high degree of purity. The results in both cases conformed to those obtained
with Tyrode as the diluting agent. In the case of citric acid the supernatant
fraction contained some of the phenolic derivatives BpF1 and BpF2. These pro-
bably arose as breakdown products of BpX1 or BpX2 during the extraction
process.
The results may be summarised as:
Nuclei.-Unchanged benzpyrene and BpX2 present throughout.
Mitrochondria.-Unchanged benzpyrene and BpX2 present throughout.
Microsomes.-BpX2 present throughout. Unchanged benzpyrene present in
all samples up to 8 hours, but only one out offive from longer time intervals.
Supernatant.-BpX1 and BpX2 regularly occurred. Unchanged benzpyrene
only found occasionally and then only in trace amounts.
It may be argued that the distribution of benzpyrene metabolites as found
is not representative of intracellular behaviour but arises as a result of adsorp-
tion during the homogenising or centrifuging processes. To overcome this
objection we have separated normal untreated livers into the same fractions as
previously. These have been resuspended in colloidal suspensions of benzpyrene
and then placed in the incubator at 37° C. for varying time intervals. Throughout
this period they were maintained in complete darkness so as to avoid any photo-
sensitising activity by the hydrocarbon. The fractions were then processed as
previously and checked for metabolites. The results are given in Table II.
TABLE II.-Benzpyrene Derivativesfound after IncubationofMouse Liver Fractions
with Colloidal Benzpyrene.
Findings.
Number Incuba-
of mice tion time. Extraction Incubation Mito- Micro- Super-
used. (hours). medium. medium. Nuclei. chondria. somes. natant.
5 . 1~ Tyrode . Tyrode .Bpx BpX, BpX BpX,
(pH-7-6) . (pH-7'6) BpX,
6 . 11 Sucrose-0-88M . Sucrose--025M . BpX2 BpX2 BpX2 BpX1
(pH-6'8) (pH-6'8)
6 . 2 . Tyrode Tyrode - - - BpX
(pH-7.6) (pH-7'6) BpX2
6 21 1 per cent citric Tyrode . BpX2 BpF2 BpX2-
acid (pH-7-6) BpF2
(pH-2-6)
8 . 16 . Tyrode . Tyrode .BpX, BpX2 BpX, (pH-7'6) (pH-7'6) BpX,
Abbreviations as in Table I.
Comparison of Tables I and II shows that the findings from in vivo experiments
are completely substantiated by the in vitro work. In some cases phenolic deri-
vatives were found in the material from the in vitro experiments, but this is not
surprising in view of Weigert and Mottram's (1946a) finding that the primary
derivatives are rapidly converted to phenolic compounds in the presence of
tissues.
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Throughout these experiments no evidence has arisen to suggest that any
other benzpyrene metabolites are formed.
DISCUSSION.
The results obtained in these experiments are consistent with previous findings
and also with data obtained with other carcinogens. We have shown that benz-
pyrene becomes distributed throughout the cell, as was found for dibenzan-
thracene by Wiest and Heidelburger (1953). The hepatic carcinogen 4-dimethyl-
aminoazobenzene has been found by Price, Miller and Miller (1948) and Price,
Miller, Miller and Weber (1949) to occur in all four fractions of rat liver. The
completely unrelated compound 2-acetylaminofluorene has been shown by Weis-
burger, Weisburger and Morris (1953) to extend to all cell fractions ofrat liver and
kidney. Danielli (1952) has also reported that nitrogen mustard penetrates
throughout and has a "diffuse" action on the cell. If this ability to spread
throughout the cell is found to be a general property of carcinogenic agents it
may prove important and help to explain the multiplicity ofapparently unrelated
biological responses that these agents can elicit.
The biological implications of these findings cannot be adequately expressed
till further experiments are undertaken, but several points are worthy ofcomment
now. From their studies with whole tissues Weigert and Mottram (1946b) con-
cluded that benzpyrene was initially oxidised to BpX1 and thenfurther changed to
BpX2 whilst still in contact with tissues. The present discovery that BpX1 only
occurs in the supernatant fraction is suggestive of its formation solely at this site
and that BpX2 is derived independently at alternative sites. This implies two
independent mechanisms of oxidation with separate but related end products.
Such a scheme also explains the fact that BpX1 appears as an excretion product
in the bile before BpX2, whilst later BpX2 predominates. Obviously, during its
passage across the cell benzpyrene will come into contact with cytoplasmic
material (extracted as supernatant) before it is absorbed by the particulate cell
components. Assuming roughly equivalent rates of formation of the two deriva-
tives it is clear that the relative amount of BpX1 to BpX2 will be higher in the
initial period.
The widespread occurrence of benzpyrene metabolism within the cell would
suggest that the oxidation processes are not specific enzyme mechanisms, since
modern evidence indicates that enzymes tend to be localised. The alternative is
that oxidation occurs as the result ofinteraction with some widespread normal cell
constituent, perhaps structural protein. Such a view is supported by the findings
of Calcutt (1949, 1950), Garzia and Dansi (1953) and Warren (1943) that benz-
pyrene can be oxidised in the presence of simple compounds (cysteine, ascorbic
acid) which occur in cells, to give end products comparable to those found during
metabolism in the animal.
SUMMARY.
1. Pooledlivers from groups of 6-8 mice which had been intravenously injected
with colloidal benzpyrene were fractionated into nuclei, mitrochondria, micro-
somes and supernatant.
2. Examinations for benzpyrene metabolites at intervals up to 24 hours
showed BpX2 exclusively in nuclei, mitochondria and microsomes. BpX1 and
BpX2 occurred in the supernatant fraction.
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3. Corresponding fractions from untreated liver were incubated at 37° C. with
colloidal benzpyrene. Metabolites were extracted as in the in vivo experiments,
thus demonstrating that the oxidation ofbenzpyrene is at sites found.
4. The results and their significance are briefly discussed.
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